Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coronary sinus outflow modulation is a physiological intervention achieved through implantation of a coronary sinus reducer device, which narrows the coronary sinus to elevate venous pressure. This leads to an increase in capillary transit time and facilitates redistribution of blood flow from better-oxygenated areas to regions affected by ischemia in the myocardium[1][2][3][5]. The approach is used in treating refractory angina and myocardial ischemia, and its therapeutic rationale is based on the principle: "if you cannot increase coronary input, decrease its output"[1]. This slows the coronary venous drainage, prolongs the exchange of oxygen and nutrients at the microvascular level, and can improve cardiac symptoms and function in eligible patients[1][2][3][5].
Increases coronary sinus pressure to slow venous outflow Extends capillary transit time, allowing more time for oxygen and nutrient exchange Redistributes blood from nonischemic to ischemic myocardial regions, improving perfusion especially in severe stenosis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coronary sinus reducer (CSR).